It’s a classic good news/bad news scenario. The bad news? U.S. Food and Drug Administration (FDA) officials keep finding the same operational problems over and over again during clinical trial […]
While the clinical trials industry doesn’t have a reputation as a haven for early adopters when it comes to technology, contract research organizations (CROs) are the driving force for the […]
To help industry better understand the agency’s latest thinking on when it may require clinical trials or postmarket studies for already-approved https://nizagara-online.net prescription drugs, the U.S. Food and Drug Administration […]
Dale Carnegie and Norman Vincent Peale notwithstanding, there are limits to the power of positive thinking when it comes to clinical trial recruitment. It’s a common problem in the industry […]
Risk-based monitoring (RBM) and risk-based quality management (RBQM) are “central to ensuring the safety of patients in clinical trials, and [are] expected to continue to grow in importance as [trials] […]